- Home
- BDRX vs IBG Comparison
BDRX vs IBG Comparison
Compare BDRX & IBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BDRX | IBG |
|---|---|---|
| Founded | 2000 | 2018 |
| Country | United Kingdom | Australia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6M | 1.5M |
| IPO Year | 2015 | 2022 |
Fundamental Metrics
Financial Performance| Metric | BDRX | IBG |
|---|---|---|
| Price | $1.30 | $0.96 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 263.0K | 56.6K |
| Earning Date | 09-12-2025 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.60 | $0.32 |
| 52 Week High | $11.88 | $6.50 |
Technical Indicators
Market Signals| Indicator | BDRX | IBG |
|---|---|---|
| Relative Strength Index (RSI) | 19.77 | 53.33 |
| Support Level | $0.60 | $0.99 |
| Resistance Level | $1.50 | $1.08 |
| Average True Range (ATR) | 0.11 | 0.09 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 7.22 | 74.06 |
Price Performance
Historical ComparisonAbout BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.
About IBG Innovation Beverage Group Limited Ordinary Shares
Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter, and retailer of a growing beverage portfolio of 70 formulations across 14 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands. The Group has two reportable geographic segments: Australia and the United States.